Study: Melanoma increases may be a matter of over-diagnosis

08/5/2005 | Medscape (free registration)

The striking increase in melanoma rates in the U.S. may be more a matter of heightened awareness and diagnostic scrutiny than the disease increasing in the population, according to a new study. In looking at Medicare claims data on patients older than 65 between 1986 and 2001, researchers found the average biopsy rates and melanomas rose, but the regional and distant disease and mortality remained stable, indicating that an over-diagnosis is taking place.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC